(Total Views: 348)
Posted On: 12/11/2017 10:04:33 PM
Post# of 30066

Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
Experimental Neurology
Volume 298, Part B, December 2017, Pages 137-147
For those that might have access:
http://www.sciencedirect.com/science/article/...8617302431
Experimental Neurology
Volume 298, Part B, December 2017, Pages 137-147
Quote:
Two newer neurotrophic factors currently being pursued for clinical application are the mesencephalic astrocyte-derived neurotrophic factor (MANF) and the ...
For those that might have access:
http://www.sciencedirect.com/science/article/...8617302431

